Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo
Clinical trial NCT07253675 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07253675
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2027-02-28
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.